PHOTO
Aug 26 (Reuters) - Britain's medicines regulator on Friday approved Novavax's COVID-19 vaccine for children aged between 12 and 17 years. (Reporting by Sinchita Mitra in Bengaluru; Editing by Krishna Chandra Eluri)
Britain approves Novavax COVID shot for 12-17 year-olds
Britain's medicines regulator on Friday approved
August 26, 2022
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
© ZAWYA 2024
